热尼胺通过NMDARs和BDNF通路改善PC12细胞中皮质类固醇诱导的毒性
Qi Ma1, Yu Ma1, Shizhuo Sun1
1Key Laboratory of Resource Biology and Biotechnology in Western China, Northwest University, Ministry of Education, Xi'an, P.R. China.
Cell biochemistry and biophysics
|July 31, 2025
概括
基尼化物 (GE) 通过减少亡和增强突触可塑性,保护神经细胞免受皮质 (CORT) 损伤. 这项研究证明了GE的存在.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 过多的皮质 (CORT) 会导致神经毒性和神经细胞损伤.
- 基尼化物 (GE) 源自Gardenia jasminoides,具有已知的抗炎和抗氧化特性.
- 了解GE对抗CORT引起的损伤的潜在神经保护机制至关重要.
研究的目的:
- 为了研究Geniposide (GE) 对PC12细胞中皮质激素 (CORT) 诱导的损伤的神经保护作用.
- 阐明涉及GE保护作用的分子通路,包括亡和突触可塑性.
- 评估GE对关键蛋白质的影响与神经元功能和生存有关.
主要方法:
- 在暴露于CORT之前,PC12细胞被GE预处理.
- 通过流式细胞计量评估细胞活力,乳酸脱酶 (LDH) 泄漏和细胞亡.
- 用于MAP2和PSD95表达的免疫光和用于蛋白质分析的西部斑点 (谷氨酸受体,BDNF通路,亡标记物).
主要成果:
- 转基因治疗显著阻止了CORT诱导的细胞活力的减少,细胞亡和LDH释放.
- GE增强了神经元标记物MAP2和PSD95.5的表达.
- 转基因通过减少Bax,Caspase-3和Caspase-9来调节亡途径,同时增加Bcl-2,并促进了BDNF途径和突触可塑性蛋白.
结论:
- 基尼化物 (GE) 对PC12细胞中CORT诱导的细胞损伤表现出显著的神经保护和抗亡作用.
- GE的保护机制包括BDNF通路的激活和Bax/Bcl-2亡通路的抑制.
- 转基因证明了作为治疗条件的治疗剂的潜力,涉及CORT诱导的神经毒性和突触功能障碍.
相关概念视频
Long-term Potentiation
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...


